Efficacy and Safety of Netakimab, A Novel Anti-IL-17 Monoclonal Antibody, in Patients with Moderate to Severe Plaque Psoriasis. Results of A 54-Week Randomized Double-Blind Placebo...

por Puig, Luís, Bakulev, Andrey L., Kokhan, Muza M., Samtsov, Alexey V., Khairutdinov, Vladislav R., Morozova, Maria A., Zolkin, Nikita A., Kuryshev, Ivan V., Petrov, Alexey N., Artemeva, Antonina V., Zinkina-Orikhan, Arina V.
Publicado 2021

Long-term data on the proposed adalimumab biosimilar BCD-057 in patients with moderate to severe psoriasis: A randomized controlled trial

por Samtsov, Alexey V., Bakulev, Andrey L., Khairutdinov, Vladislav R., Kokhan, Muza M., Korotaeva, Tat’yana V., Minullin, Iskander K., Vylegzhanina, Olga A., Dubenskiy, Valery V., Khalilov, Bulat V., Khotko, Alkes A., Zykova, Olga S., Chumachenko, Irina V., Lukyanov, Alexander M., Artemeva, Antonina V., Pukhtinskaia, Polina P.
Publicado 2022